For your skin
A gentle smoother and skin-soother. Reduces flakiness and helps the surface look more even.
Want the science? Keep reading ↓Mechanism of action
Keratolytic and soothing agent that promotes cell proliferation and smooths rough texture.
Why we tier this anecdotal
6 cited papers across 3 countries. Most of what's cited here is mechanism-level or in-vitro work. We track this as Anecdotal until controlled clinical trials accumulate.
Layering matrix
Cited research
Xu Z et al., Efficacy and Safety of Topical Compound Heparin Sodium Allantoin Gel for the Treatment of Rosacea, Journal of Cosmetic Dermatology 2025;24(4):e70129 — RCT (n=82, 12 weeks): allantoin gel improved erythema and alleviated itching/burning vs traditional therapy
Tan C et al., The combination of allantoin, bisabolol, D-panthenol and dipotassium glycyrrhizinate mitigates UVB-induced PGE2 synthesis by keratinocytes, International Journal of Cosmetic Science 2024;46(5):691-701 — in vitro: allantoin combination reduced UVB-induced PGE2, IL-1α, IL-6, IL-8, TNFα
Saucedo-Acuna RA et al. (Mexico), Characterization and In Vivo Assay of Allantoin-Enriched Pectin Hydrogel for the Treatment of Skin Wounds, International Journal of Molecular Sciences 2023;24(8):7377 — allantoin-pectin hydrogel reduced wound healing time by ~71% with complete closure at day 15 in rat model
Leeyaphan C et al., A randomized controlled trial to compare the effectiveness and safety of adsorbent lotion containing tapioca starch, spent grain wax, B. parkii extract, A. spinosa kernel oil, A. barbadensis, rosehip oil, and allantoin with a low-potency topical corticosteroid in the treatment of intertrigo, Journal of Cosmetic Dermatology 2022;21(2):679-688 — allantoin-containing adsorbent lotion equivalent to low-potency steroid for intertrigo
Paller AS et al., Efficacy and tolerability of the investigational topical cream SD-101 (6% allantoin) in patients with epidermolysis bullosa: a phase 3, randomized, double-blind, vehicle-controlled trial (ESSENCE study), Orphanet Journal of Rare Diseases 2020;15(1):158 — phase 3 RCT; 6% allantoin not superior to vehicle for EB wound closure
Araujo LU et al. (Brazil), Profile of wound healing process induced by allantoin, Acta Cirurgica Brasileira 2010;25(5):460-6 — allantoin accelerated wound healing via inflammatory regulation and stimulation of fibroblast proliferation and ECM synthesis
Sources: 10 clinical journals and regulatory databases across the US, EU, Korea, Japan, and China. Every entry points to a specific document. See methodology for the full list and what each outcome label means.